Carisma Therapeutics Inc (NASDAQ:CARM)

Delayed Data
As of Dec 07
 +0.17 / +7.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Carisma Therapeutics Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +290.62% increase from the last price of 2.56.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Carisma Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.26%
Growthannually -32.00%


Growthquarterly -36.91%
Growthannually -80.52%
Key to the earnings and sales forecast charts.